MEGABEAM ENDOCULAR PROBE AND ASPIRATING ENDOCULAR PROBE
K-Number: K113792 · 2012-01-19
Advertisement
Device Summary
Frequently Asked Questions
What is the MEGABEAM ENDOCULAR PROBE AND ASPIRATING ENDOCULAR PROBE?
MEGABEAM ENDOCULAR PROBE AND ASPIRATING ENDOCULAR PROBE is a medical device that received FDA 510(k) clearance on 2012-01-19. The listed applicant is Biolitec Medical Devices, Inc.. The 510(k) number is K113792.
When did MEGABEAM ENDOCULAR PROBE AND ASPIRATING ENDOCULAR PROBE receive FDA 510(k) clearance?
MEGABEAM ENDOCULAR PROBE AND ASPIRATING ENDOCULAR PROBE received FDA 510(k) clearance on 2012-01-19, under 510(k) number K113792.
Who is the listed applicant for MEGABEAM ENDOCULAR PROBE AND ASPIRATING ENDOCULAR PROBE?
The FDA 510(k) record lists Biolitec Medical Devices, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for MEGABEAM ENDOCULAR PROBE AND ASPIRATING ENDOCULAR PROBE?
The FDA product code for MEGABEAM ENDOCULAR PROBE AND ASPIRATING ENDOCULAR PROBE is GEX. This falls under the Gastroenterology category.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Biolitec Medical Devices, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: GEX)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement